In 1961, Dr. Mildred Stahlman pioneered the first newborn intensive care unit (NICU) in the country to use monitored respiratory therapy on infants with damaged lungs [REF].
In November 2016, researchers at Vanderbilt University Medical Center and Washington University School of Medicine isolated a human monoclonal antibody that in a mouse model "markedly reduced" infection by the Zika virus [REF].